The Kidney Cancer Association (KCA) is a charitable organization made up of patients, caregivers, physicians, researchers, and other health professionals. The KCA partners with the National Cancer Institute and American Society for Clinical Oncology on research projects. This site, which can be translated to 24 different languages, provides basic statistics about kidney cancer, its diagnosis, and treatment. You can read survivor stories, watch videos, and listen to their official podcasts (digital audio recordings that you can listen to on your computer, and/or download to a mobile device).
It also features the KCA online forum, a Web community with over 1,500 members where you can trade information with other kidney cancer patients and caregivers. To access the forum, you will first need to create an account, which requires you to supply your email address, first and last name, city, state, and phone number.
By creating a separate, free account with Emerging Med, you can also search for clinical trials that match your personal profile using KCA's confidential Clinical Trial Matching Service. This service also includes a toll-free number, 800-501-5219, that connects you to a Clinical Trial Specialist.
KCA's Nurse Hotline, which may be accessed by calling 503-215-7921, answers questions about the treatment of kidney cancer and provides referrals to kidney cancer specialists in the United States.
Here you will find comprehensive information from the National Cancer Institute about kidney (renal cell) cancer, and Wilms tumor, a type of kidney cancer that usually develops in children under the age of five, including risk factors, symptoms, diagnosis, and treatment options. There is also information about treatment options by disease stage and results of important kidney cancer clinical trials. Information is presented in two formats -- for patients and for health professionals -- and the site indicates when information was last updated. You can also search to find clinical trials involving patients with kidney cancer. Information is also available in Spanish.
